Lymphoma, Follicular Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting lymphoma, follicular clinical trials across 8 countries. Studies span Phase 1, Phase 2, Not Applicable. Top locations include Manchester, United Kingdom, Beijing, Beijing Municipality, China, Bundang Gu, Gyeonggi-do, South Korea. Updated daily from ClinicalTrials.gov.


Lymphoma, Follicular Trials at a Glance

8 actively recruiting trials for lymphoma, follicular are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Manchester, Beijing, and Bundang Gu. Lead sponsors running lymphoma, follicular studies include City of Hope Medical Center, Essen Biotech, and Cancer Research UK.

Browse lymphoma, follicular trials by phase

Treatments under study

About Lymphoma, Follicular Clinical Trials

Looking for clinical trials for Lymphoma, Follicular? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymphoma, Follicular trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymphoma, Follicular clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC200 enrolled4 locationsNCT07519772
Recruiting
Phase 1

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedMature T-Cell and NK-Cell Non-Hodgkin LymphomaFollicular Helper T-Cell Lymphoma+3 more
City of Hope Medical Center20 enrolled1 locationNCT07278856
Recruiting

Long-term Ovarian Fertility in Patients Treated for Lymphoma.

Lymphoma, Follicular
University Hospital, Lille270 enrolled1 locationNCT05616325
Recruiting

Long-term Follow up Local Registry Study of Kymriah in South Korea

B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals500 enrolled16 locationsNCT06785818
Recruiting
Phase 1Phase 2

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

Diffuse Large B Cell LymphomaAcute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in Relapse+4 more
Essen Biotech75 enrolled1 locationNCT06213636
Recruiting
Phase 1Phase 2

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Lymphoma, Non-HodgkinLymphoma, B-CellLarge B-cell Lymphoma+3 more
Cancer Research UK84 enrolled7 locationsNCT06045910
Recruiting
Not Applicable

MOLyF : Bone Marrow and Follicular Lymphoma

Lymphoma, Follicular
Rennes University Hospital200 enrolled1 locationNCT06608147
Recruiting
Phase 2

Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

Lymphoma, Follicular
Oslo University Hospital80 enrolled3 locationsNCT05849857